Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasms by Site × Methods × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 25 Neoplasms 23 Uterine Cervical Neoplasms 10 Lung Neoplasms 10 Colorectal Neoplasms 8 Colonic Neoplasms 8 Motor Activity 7 Urinary Bladder Neoplasms 6 Rectal Neoplasms 6 Vulvar Neoplasms 5 Obesity 5 Endometrial Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Melanoma 4 Head and Neck Neoplasms 4 Anxiety Disorders 4 Stomach Neoplasms 3 Sarcoma 3 Hematopoietic and Lymphoid System Neoplasm 3 Depression 3 Carcinoma, Ovarian Epithelial 3 Breast Carcinoma In Situ 3 Vaginal Neoplasms 2 Testicular Neoplasms 2 Skin Neoplasms 2 Psychological Well-Being 2 Prostatic Neoplasms 2 Papillomavirus Infections 2 Pancreatic Neoplasms 2 Pain 2

Interventions

Gemcitabine 4 Cyclophosphamide 4 130-nm albumin-bound paclitaxel 4 padeliporfin 3 napabucasin 3 Pemetrexed 3 Nivolumab 3 Albumin-Bound Paclitaxel 3 ficlatuzumab 2 Trastuzumab 2 Paclitaxel 2 Leucovorin 2 Irinotecan 2 Fluorouracil 2 Bevacizumab 2 sotorasib 1 ribociclib 1 relatlimab 1 pralsetinib 1 pembrolizumab 1 pamiparib 1 osimertinib 1 nintedanib 1 ipatasertib 1 guadecitabine 1 glutathione pegylated liposomal doxorubicin 1 exemestane 1 entinostat 1 durvalumab 1 cobimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03569605 2021-04-01

IMPACT

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed

Motor Activity, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon ⚡